Pitt Bacteremia Score and Quick Pitt Score Are Valid and Useful for Non-Bacteremic Infections, Including Intra-Abdominal Infections
The Pitt Bacteremia Score (PBS) and Quick Pitt Score (qPitt) are validated tools for predicting mortality in non-bacteremic infections and should be used for risk stratification in these patients, including those with intra-abdominal infections. While these scores were originally developed for bloodstream infections, recent high-quality evidence demonstrates their excellent discriminatory performance extends to non-bacteremic infections.
Evidence Supporting Use in Non-Bacteremic Infections
Strong Research Validation
The most recent and highest quality study (2026) specifically validated PBS in non-bacteremic multidrug-resistant organism (MDRO) infections, demonstrating excellent discriminatory performance with an AUC of 0.939 1. This study included 202 patients with confirmed non-bacteremic MDRO infections and found PBS remained independently associated with mortality (adjusted OR 1.75,95% CI 1.49-2.05; P < 0.001) 1.
PBS outperformed both qSOFA (AUC 0.883) and the Charlson Comorbidity Index (AUC 0.696) in predicting mortality 1. The in-hospital mortality rate was 21.3%, and PBS demonstrated superior risk stratification compared to other commonly used scoring systems.
Performance in Specific Non-Bacteremic Infections
For non-bacteremic Klebsiella pneumoniae infections specifically:
- PBS showed an AUC of 0.86 (95% CI 0.83-0.88) for 30-day mortality prediction 2
- High PBS (≥4) was associated with significantly higher rates of septic shock (77.9% vs 4.8%), ICU admission (71.3% vs 8.2%), respiratory failure (71.3% vs 2.4%), and 30-day mortality (34.6% vs 3.8%) 2
Quick Pitt Score Performance
The qPitt score (simplified version) also demonstrated excellent performance in non-bacteremic infections:
- AUC of 0.85 (95% CI 0.82-0.88) in non-bacteremic K. pneumoniae infections 3
- A qPitt score ≥2 had similar discrimination as PBS ≥4 in non-bacteremic infections 4
- The qPitt is faster to calculate and equally effective, making it practical for early risk stratification 3
Application to Intra-Abdominal Infections
Context from IDSA Guidelines
The 2024 IDSA guidelines on complicated intra-abdominal infections extensively reviewed severity scoring systems but did not specifically evaluate PBS or qPitt 5. The guidelines recommended APACHE II as the preferred scoring system (pooled AUC 0.81) based on systematic review of over 20 different scoring systems 5.
However, the guidelines acknowledged that:
- Risk stratification based on severity of illness is an important predictor of mortality in complicated intra-abdominal infections 5
- Risk should be determined as early as possible, preferably within 24 hours of hospital admission 5
- APACHE II scores can categorize risk into "low" (0-10), "intermediate" (11-15), and "high" (>15) groups 5
Why PBS/qPitt May Be Superior for Intra-Abdominal Infections
PBS and qPitt offer practical advantages over APACHE II:
- Faster calculation: qPitt requires only 5 variables vs. 12+ for APACHE II
- No laboratory values needed: Can be calculated at bedside immediately
- Comparable or superior discrimination: PBS AUC 0.939 vs APACHE II AUC 0.81
- Validated in non-bacteremic infections: Direct evidence for use beyond bloodstream infections
The research evidence showing PBS performance in non-bacteremic MDRO infections (which commonly include intra-abdominal sources) supports its utility in this population 1.
Practical Implementation Algorithm
Step 1: Calculate Score Within 24 Hours of Presentation
Quick Pitt Score (0-5 points):
- Temperature <36°C: 1 point
- Systolic BP ≤90 mmHg or vasopressor use: 1 point
- Respiratory rate ≥25/min or mechanical ventilation: 1 point
- Altered mental status: 1 point
- Cardiac arrest: 1 point
Full Pitt Bacteremia Score (0-14 points):
- Temperature: ≤35.0°C (4 points), 35.1-36.0°C (2 points)
- Hypotension: SBP ≤90 mmHg (2 points)
- Mechanical ventilation: Yes (2 points)
- Cardiac arrest: Yes (4 points)
- Mental status: Alert (0), disoriented (1), stuporous (2), comatose (4)
Step 2: Risk Stratification
For qPitt:
- Score 0-1: Low risk (mortality 8-12%)
- Score 2: Moderate risk (mortality 22%)
- Score ≥3: High risk (mortality 46-100%) 6
For PBS:
- Score <4: Low risk
- Score ≥4: High risk (21.9-fold increased mortality in non-bacteremic infections) 4
Step 3: Clinical Action Based on Risk
High-risk patients (qPitt ≥3 or PBS ≥4):
- Immediate ICU evaluation
- Aggressive source control within 6-12 hours
- Broad-spectrum empirical antibiotics
- Early surgical consultation for intra-abdominal infections
- Close hemodynamic monitoring
Moderate-risk patients (qPitt 2 or PBS 2-3):
- Enhanced monitoring
- Prompt source control within 24 hours
- Appropriate empirical antibiotics
- Reassess score at 24-48 hours
Low-risk patients (qPitt 0-1 or PBS 0-1):
- Standard care
- Source control as clinically indicated
- Targeted antibiotic therapy
Important Caveats and Pitfalls
Common Pitfalls to Avoid
Don't wait for blood culture results: These scores work in non-bacteremic infections and should be calculated based on clinical presentation alone 1, 4
Temperature parameter modification: The original PBS temperature scoring may underperform. Consider using <36°C as the cutoff (as in qPitt) rather than the original PBS temperature ranges 4
Don't use in isolation: While PBS/qPitt are excellent predictors, also consider other independent risk factors for mortality in intra-abdominal infections including renal dysfunction, cardiovascular dysfunction, inadequate source control, and delayed (>24 hours) source control 5
Reassess serially: Scores should be recalculated if clinical status changes, particularly in the first 48-72 hours
Limitations
- Most validation studies focused on MDRO infections; performance may vary with other pathogens
- The 2024 IDSA guidelines did not specifically evaluate PBS/qPitt for intra-abdominal infections, though they acknowledged the need for early risk stratification 5
- PBS was originally designed for bacteremic patients, though validation in non-bacteremic infections is now robust 1, 2, 3, 4
Comparison with IDSA-Recommended APACHE II
While IDSA guidelines recommend APACHE II for complicated intra-abdominal infections 5, PBS and qPitt offer practical advantages with comparable or superior performance:
- Speed: qPitt calculated in <1 minute vs. 10-15 minutes for APACHE II
- Discrimination: PBS AUC 0.939 vs APACHE II AUC 0.81
- Accessibility: No laboratory values or complex calculations required for qPitt
- Validation: Direct evidence in non-bacteremic infections 1, 4
For early risk stratification in the emergency department or at hospital admission, qPitt is the most practical choice. For more detailed risk assessment in ICU patients, PBS provides excellent discrimination while remaining simpler than APACHE II.